Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx266
PubMed Identifier: 28525534
Publication URI: http://europepmc.org/abstract/MED/28525534
Type: Journal Article/Review
Volume: 28
Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology
Issue: 8
ISSN: 0923-7534